1492 Capital Management LLC Pacira Bio Sciences, Inc. Transaction History

1492 Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$30.68 - $40.09 $528,186 - $690,189	-17,216 Reduced 17.77%	79,687 $2.44 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $47.5 $202,994 - $266,950	5,620 Added 6.16%	96,903 $3.88 Million
Q1 2023 May 12, 2023	BUY	$35.53 - $43.38 $2.67 Million - $3.26 Million	75,130 Added 465.11%	91,283 $3.73 Million
Q3 2022 Nov 10, 2022	SELL	$51.24 - $58.89 $153 - $176	-3 Reduced 0.02%	16,153 $859,000
Q2 2022 Aug 10, 2022	BUY	$51.49 - $81.64 $182,583 - $289,495	3,546 Added 28.12%	16,156 $942,000
Q1 2022 May 12, 2022	BUY	$60.03 - $76.49 $756,978 - $964,538	12,610 New	12,610 $962,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of 1492 Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on 1492 Capital Management LLC with notifications on news.